Companies › SLDB

SOLID BIOSCIENCES INC (SLDB)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001707502 · EDGAR filings · Updated 2026-07-07

SOLID BIOSCIENCES INC (SLDB) has reported institutional ownership of 101.3%, with 142 institutional managers holding positions valued at $717.4M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-07 — Insider transaction reported (Form 4)
• 2026-06-24 — Initial insider ownership filed (Form 3)
• 2026-06-24 — SCHEDULE 13D/A filed
• 2026-06-11 — Insider transaction reported (Form 4)
• 2026-06-11 — Insider transaction reported (Form 4)
• 2026-06-11 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SOLID BIOSCIENCES INC has 142 institutional holders and institutional ownership of 101.3%.

Insider activity

Insiders reported 62 transactions (0 buys, 29 sells) across 8 reporting insiders, with a net reported value of −$2.68M.

Data flags from SEC filings

Related companies

SCHRODINGER INC (SDGR) · GERON CORP (GERN) · IRADIMED CORP (IRMD) · VOR BIOPHARMA INC (VOR) · JADE BIOSCIENCES INC (JBIO) · LB PHARMACEUTICALS INC (LBRX)